Business
– Jeremy Levin – / By David Frank / This week revealed the 2012 salary for the CEO of Teva Pharmaceuticals (NASDAQ: TEVA). Teva...
Hi, what are you looking for?
– Jeremy Levin – / By David Frank / This week revealed the 2012 salary for the CEO of Teva Pharmaceuticals (NASDAQ: TEVA). Teva...
– The Southern District of New York dismissed Teva’s lawsuit against Mylan for the infringement of patents on its MS treatment. – Teva Pharmaceutical...
– / By Alan Gallindoss/ On June 12th Jewish Business News reported that Teva had settled a major lawsuit brought against it by Pfizer...
– Six dual-listed companies with an aggregate market cap of NIS 6.5 billion delisted from the TASE in 2010-12. – – / By Shiri...
– The French pharmaceutical authorities head has said that there were no deaths because of the wrong pills packaged in a heart failure treatment....
– The UK price of the impotence treatment, which costs the National Health Service £40 million annually, is expected to fall from £10 to...
– “We have not asked for any tax benefit from anyone in the government in relation to registration of intellectual property for Teva.” –...
– Teva will pay $40 million for the lung disease drug developer and up to $125 million in milestone payments plus royalties. – –...
– – / By Alan Gallindoss / Global pharmaceutical company Pfizer announced today that Israeli company Teva Pharmaceuticals Industries and Indian generic drug manufacturer...
– May Have Led to a Number of Patient Deaths in France. – / By Alan Gallindoss / Pharmaceutical trade magazine “in-pharmetechnologist.com” has...